Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
- PMID: 8534863
- DOI: 10.1007/BF00666036
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
Abstract
Vascular endothelial growth factor (VEGF)/vascular permeability factor (VPS) plays a crucial role for the vascularization of tumors including breast cancers. Tumors produce ample amounts of VEGF, which stimulates the proliferation and migration of endothelial cells (ECs), thereby inducing tumor vascularization by a paracrine mechanism. VEGF receptors (VEGF-Rs) are highly expressed by the ECs in tumor blood vessels. VEGF expression can be induced in various cell types by a number of stimuli including hypoxia, differentiation, growth factors and tumor promoters of the phorbol ester class, such as TPA. The VEGF inductive pathways comprise kinases, oncogenes, tumor suppressor genes, and steroid hormone transcription factors, many of which seem to converge on the activator protein (AP-1) transcription factor. Much less is known about the regulation of VEGF-R expression, which is restricted to ECs. This expression is greatly enhanced in diseased tissue such as solid tumors. So far, it appears that growth factors, cytokines, and tumor promoters are involved in the control of VEGF-R expression. Here we review current knowledge about the regulation of the expression of VEGF and its receptors.
Similar articles
-
Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.Int J Cancer. 1994 Nov 15;59(4):520-9. doi: 10.1002/ijc.2910590415. Int J Cancer. 1994. PMID: 7525492
-
Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis.Carcinogenesis. 1997 Jun;18(6):1155-61. doi: 10.1093/carcin/18.6.1155. Carcinogenesis. 1997. PMID: 9214597
-
Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer.Cancer Res. 1996 May 1;56(9):2013-6. Cancer Res. 1996. PMID: 8616842
-
[Advances in the study of the role of vascular endothelial growth factor and its receptor in tumor angiogenesis and its relation with anti-angiogenesis effect].Zhonghua Bing Li Xue Za Zhi. 1997 Aug;26(4):248-50. Zhonghua Bing Li Xue Za Zhi. 1997. PMID: 10072871 Review. Chinese. No abstract available.
-
Vascular endothelial growth factor (VEGF) and its receptors.FASEB J. 1999 Jan;13(1):9-22. FASEB J. 1999. PMID: 9872925 Review.
Cited by
-
Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors.Curr Treat Options Oncol. 2007 Feb;8(1):15-27. doi: 10.1007/s11864-007-0022-4. Curr Treat Options Oncol. 2007. PMID: 17634832 Review.
-
Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy.EBioMedicine. 2017 Mar;17:45-56. doi: 10.1016/j.ebiom.2017.02.019. Epub 2017 Feb 22. EBioMedicine. 2017. PMID: 28258923 Free PMC article.
-
[Markers in patients with squamous cell carcinoma of the oral cavity. Expression and long-term follow-up of VEGF, FLT-1 and Tie2 in serum].HNO. 2004 Mar;52(3):235-41. doi: 10.1007/s00106-003-0915-x. HNO. 2004. PMID: 15007517 German.
-
Oncogenes as inducers of tumor angiogenesis.Cancer Metastasis Rev. 1995 Dec;14(4):263-77. doi: 10.1007/BF00690598. Cancer Metastasis Rev. 1995. PMID: 8821090 Review.
-
NF-κB signaling pathway in tumor microenvironment.Front Immunol. 2024 Oct 18;15:1476030. doi: 10.3389/fimmu.2024.1476030. eCollection 2024. Front Immunol. 2024. PMID: 39493763 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical